Sarafan ChEM-H

The Stanford researcher views plants as nature’s ultimate chemists. Her work has the potential to innovate everything from food allergies to cancer treatment.

Last year’s winners of the Undergraduate Entrepreneurship Program are developing a gene therapy to treat a form of muscular dystrophy. For team leader Heloise Hoffmann, the mission is personal.

A technique to see DNA as it moves in living cells could offer novel fundamental insights into biology.

Bioengineering Professor Michael Fischbach shares his framework for choosing impactful problems to work on and finding optimal solutions.

A new method for delivering drugs could make it possible for chemotherapy patients to take pills rather than receive infusions.

A new method for relocating proteins that have been misplaced in cells could mean new treatments for cancers and neurodegeneration.

An inexpensive kit developed by Stanford undergraduates brings hands-on lessons in the gene-editing technology to high school classrooms.

A method that combines a large language model with data about a protein’s 3D shape could make it quicker and easier to develop medications.

The Sarafan ChEM-H Institute scholar is building a multidisciplinary lab to explore the reengineering of immune cells. Before coming to Stanford, she says, “I was thinking in terms of understanding. Now I feel that I can start thinking in terms of creating.”

New research from Stanford and the Arc Institute could lead to a new and more effective immunotherapy and help clinicians better predict patient response to existing medicines.